Barclays’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,493
Closed -$271K 5486
2020
Q1
$271K Sell
2,493
-3,588
-59% -$641K ﹤0.01% 4068
2019
Q4
$1.58M Sell
6,081
-2,962
-33% -$1.1M ﹤0.01% 3236
2019
Q3
$4.76M Buy
9,043
+5,276
+140% +$3.91M ﹤0.01% 1893
2019
Q2
$3.54M Buy
+3,767
New +$3.79M ﹤0.01% 2231

Other funds holding ACB

Barclays's ACB Position: Q1 2026 in Review

Barclays reduced its Aurora Cannabis (ACB) stake by 18% in Q1 2026, selling an estimated $22.6K and leaving 27,717 shares worth $90.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4068.

Barclays first reported a position in ACB in Q4 2018 and has held it in 23 quarters since. The position peaked at $3.12M in Q2 2019. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Barclays held 27,717 shares of Aurora Cannabis worth $90.6K as of Q1 2026.
  • Barclays sold 5,992 Aurora Cannabis shares in Q1 2026, an estimated $22.6K.
  • Aurora Cannabis made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4068 holding.
  • Barclays first reported a position in Aurora Cannabis in Q4 2018 and has held it in 23 quarters since.
  • Barclays's Aurora Cannabis position peaked at $3.12M in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.